Zepbound Lawsuit: The Claims, the MDL, the Status
Zepbound lawsuit: what happened, what it means for patients, and where to read the record.
- Active ingredient
- tirzepatide
- Manufacturer
- Eli Lilly
- How it is taken
- Weekly injection (pen or vial)
- FDA-approved for
- Weight loss, Sleep apnea
Zepbound overview
Its half-life lasts 5 to 6 days. By 5.5 d, half has left the body, and five half-lives (27.5 d) leave about 3%.
In SURMOUNT-1 over 72 weeks, people lost 20.9% of body weight, compared with 3.1% on placebo.
Monthly prices in US dollars include the list price and self-pay offers. Each comes from the maker's price page.
Sources: FDA label (DailyMed), Eli Lilly 1 2, cnbc.com.